Eric Dobmeier Atara Biotherapeutics, Inc. (ATRA) insider trading activity

ATRA Quotes by TradingView

Eric Dobmeier is of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 563,325 shares of ATRA, which is worth approximately $6.57 Million. The most recent transaction as insider was on Nov 10, 2023, when has been sold 446,825 shares (Common Stock) at a price of $0.23 per share, resulting in proceeds of $102,769. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 563K
0% 3M change
0% 12M change
Total Value Held $6.57 Million

ERIC DOBMEIER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2023
BUY
Open market or private purchase
$102,769 $0.23 p/Share
446,825 Added 44.23%
563,325 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
57,000 Added 32.85%
116,500 Common Stock
Jun 23 2022
BUY
Grant, award, or other acquisition
-
20,500 Added 25.62%
59,500 Common Stock
Jun 08 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 22.0%
39,000 Common Stock

Also insider at

ADPT
Adaptive Biotechnologies Corp Healthcare
Director
KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
President, CEO
GPCR
Structure Therapeutics Inc.
JANX
Janux Therapeutics, Inc. Healthcare
ED

Eric Dobmeier

Seattle, WA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRA